Adrian Hepner's Net Worth
$495 Thousand
Who is Adrian Hepner?
Adrian Hepner does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include EAGLE PHARMACEUTICALS, INC., and Coya Therapeutics, Inc..
SEC CIK
Adrian Hepner's CIK is 0001637347
Past Insider Trading and Trends
2018 was Adrian Hepner's most active year for acquiring shares with 3 total transactions. Adrian Hepner's most active month to acquire stocks was the month of December. 2020 was Adrian Hepner's most active year for disposing of shares, totalling 2 transactions. Adrian Hepner's most active month to dispose stocks was the month of December. 2023 saw Adrian Hepner paying a total of $0.00 for 130,000 shares, this is the most they've acquired in one year. In 2020 Adrian Hepner cashed out on 2,445 shares for a total of $141,272.10, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
EAGLE PHARMACEUTICALS, INC. (EGRX) Snapshot price: $5.33
EVP and Chief Medical OfficerAdrian Hepner owns 48,784 units of Common Stock which is worth $260,018.72. In the year 2015 Adrian Hepner acquired a total of 52,000 shares in EAGLE PHARMACEUTICALS, INC., Adrian also disposed a total of 3,216 shares of EAGLE PHARMACEUTICALS, INC. equalling to $173,137.53.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.23% | -1.63K |
$57.98 | -$94,507.40 | 48.78K |
Jan 23
| |||
Form 4
| +85.15% | 23.18K |
$57.38 | -$46,764.70 | 50.41K |
Jan 5 - Jan 7
| |||
Form 4
| +202.54% | 18.23K |
$41.33 | -$31,865.43 | 27.23K |
Jan 7 - Jan 23
| |||
Form 4
|
∞
| 9K |
—
|
—
| 9K |
Jan 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Coya Therapeutics, Inc. (COYA) Snapshot price: $6.14
Chief Medical OfficerAdrian Hepner owns 10,000 units of Common Stock, par value $0.0001 per share which is worth $61,400.00.acquired a total of 10,000 shares in Coya Therapeutics, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
|
∞
| 10K |
—
|
—
| 10K |
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||